Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC) [Phase 3]
Phase 3 study evaluating boceprevir in combination with pegylated interferon alfa-2b and ribavirin for genotype 1 chronic hepatitis C in men…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluated a behavioral intervention among injection drug users who were uninfected with HIV and Hepatitis C.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients [Phase 4]
Phase 4 trial evaluating pegylated interferon alfa-2a plus ribavirin for chronic hepatitis C in renal transplant recipients; study completed…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients [Phase 4]
A Phase 4 study evaluating treatment for chronic hepatitis C in HIV-positive patients with normal transaminases has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance [Phase 2]
Phase 2 trial assessing pioglitazone before peginterferon and ribavirin for Hepatitis C in HIV/HCV-coinfected patients with insulin resistan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: 36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8 [Phase 4]
A Phase 4 clinical trial update comparing 36 weeks versus 48 weeks of PegIntron plus Ribavirin in hepatitis C patients who did not have a ra…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection [Phase 2]
A Phase 2 clinical trial evaluating Everolimus for preventing fibrosis progression in liver transplant patients with recurrent hepatitis C; …
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Individualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis C [Phase 4]
Phase 4 trial investigating individualized duration of pegylated interferon plus ribavirin for chronic hepatitis C (genotype 1) has complete…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin [Phase 4]
This Phase 4 trial evaluating a combination of pegylated interferon and ribavirin in chronic hepatitis C patients who relapsed after prior t…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir. [Phase 1]
Phase 1 trial evaluating drug-drug interactions between etravirine or rilpivirine and telaprevir; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)
An observational study evaluating the effect of PegIntron plus Rebetol in chronic hepatitis C patients with genotype 1 and low viral load; t…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin [Phase 2]
Phase 2 clinical trial examining adding fluvastatin and rosuvastatin to pegylated interferon and ribavirin for chronic hepatitis C; the stud…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy [Phase 3]
This Phase 3 trial evaluated the efficacy and safety of MP-424 in combination with peginterferon alfa-2b and ribavirin in adults with chroni…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy [Phase 3]
Phase 3 trial evaluating MP-424 in combination with peginterferon alfa-2b and ribavirin for chronic hepatitis C in patients who relapsed aft…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C [Phase 3]
Phase 3 trial evaluating MP-424 with peginterferon alfa-2b and ribavirin in treatment-naïve chronic hepatitis C has completed and posted res…
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients [Phase 2]
A Phase 2 clinical trial of Emricasan, a caspase inhibitor, for chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)
A completed observational trial assessing relapse rates in Hepatitis C patients treated with peginterferon alfa-2b plus ribavirin in routine…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease [Phase 3]
Phase 3 trial evaluating eltrombopag to initiate and maintain interferon antiviral treatment in subjects with chronic hepatitis C-related li…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Fluvastatin Versus Hepatitis C Virus [NA]
This clinical trial update indicates that the study comparing fluvastatin to Hepatitis C has completed. No phase information is provided.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV) [Phase 2]
Phase 2 dose-finding trial of taribavirin for chronic hepatitis C completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection [Phase 1]
Phase 1 clinical trial assessing safety, tolerability, pharmacokinetics and antiviral activity of GS-9669 in adults with chronic hepatitis C…
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices [Phase 3]
Phase 3 randomized trial evaluating initiation of methadone in primary care to prevent Hepatitis C transmission among individuals with subst…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of INX-08189 in treatment-naïve adults chronically infected with hepatitis C (Genot…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects [Phase 1]
Phase 1 trial in healthy subjects comparing the relative bioavailability of three new telaprevir formulations.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy [Phase 3]
Phase 3 trial evaluating the efficacy of daily-dose consensus interferon plus ribavirin for chronic hepatitis C has completed.